In our study, we hypothesized that off-target interactions of specificdrugs with gut hormone receptors GLP1R, GIPR and GCGR could be a way to compensate for the negative influence of each on glucose homeostasis leading to drug-induced diabetes. Here, GLP1R is linked to diabetes mellitus.